Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV types 1 and 2

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 3, 2003, Pages 388-393

  Mbopi Kéou, Francois Xavier ^a,g   Bélec, Laurent ^c   Dalessio, Julie ^d,e   Legoff, Jérôme ^c   Grésenguet, Gérard ^e   Mayaud, Philippe ^b   Brown, David W G ^a   Morrow, Rhoda Ashley ^d,f  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e CNRMST ^*  (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CHEMOLUMINESCENCE; FEMALE; GENETICS; GENITAL TRACT INFECTION; HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOLOGY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; SEROLOGY; UTERINE CERVIX; UTERINE CERVIX MUCUS; VAGINA; VIROLOGY; VIRUS SHEDDING; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CERVIX MUCUS; CERVIX UTERI; DNA, VIRAL; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOGLOBULIN ISOTYPES; MIDDLE AGED; NEUTRALIZATION TESTS; SEROLOGIC TESTS; VAGINA; VIRUS SHEDDING;

EID: 17144444134     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.3.388-393.2003     Document Type: Article

References (33)

1. Ashley, R., A. Wald, and L. Corey. 1994. Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection. J. Virol. 8:5284-5286.
2. Ashley, R. L., L. Corey, J. Dalessio, P. Wilson, M. Remington, G. Barnum, and P. Trethewey. 1994. Protein-specific antibody responses to primary genital herpes simplex virus type 2 infections. J. Infect. Dis. 170:20-26.
3. Ashley, R. L., J. Dalessio, and R. E. Sekulovish. 1997. A novel method to assay herpes simplex virus neutralizing antibodies using BHKICP6LacZ-5 (ELVIS) cells. Viral Immunol. 4:213-220.
4. Ashley, R. L., F. M. Crisostomo, M. Doss, R. E. Sekulovich, R. L. Burke, M. Shaughnessy, L. Corey, N. L. Polissar, and A. G. Langenberg. 1998. Cervical antibody responses to a herpes simplex virus type 2 glycoprotein subunit vaccine. J. Infect. Dis. 178:1-7.
5. Belec, L., T. Dupré, T. Prazuck, C. Tévi-Bénissan, J. M. Kanga, O. Pathey, X. S. Lu, and J. Pillot. 1995. CVS overproduction of specific IgG to human immunodeficiency virus (HIV) contrasting with normal or impaired local response in HIV infection. J. Infect. Dis. 172:691-697.
6. Belec, L., D Meillet, M. Levy, A. J. Georges, C. Tevi-Benissan, and J. Pillot. 1995. Dilution assessment of CVS secretions obtained by vaginal washing for immunological assays. Clin. Diagn. Lab. Immunol. 2:57-61.
7. Berneman, A., L. Belec, V. A. Fischetti, and J. P. Bouvet. 1998. The specific patterns of human immunogloblin G antibodies in serum differ from those in autologous secretions. Infect. Immun. 66:4163-4168.
8. Brandtzaeg, P. 1992. Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections. J. Infect. Dis. 165(Suppl. 1):S167-S176.
9. Coughlan, B. M., and G. R. Skinner. 1977. Antibody activity to type 1 and type 2 herpes simplex virus in human cervical mucus. Br. J. Obstet. Gynaecol. 84:622-629.
10. Dalessio, J., and R. L. Ashley. 1992. Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 Western immunoblot. J. Clin. Microbiol. 4:1005-1007.
11. Eberle, R., and R. J. Courteney. 1989. Topological distribution of virus-specific and cross-reactive antigenic determinants on the gB glycoprotein of herpes simplex viruses. J. Med. Virol. 27:309-316.
12. Espy, M. J., J. Aslanzadeh, and T. F. Smith. 1993. PCR detection of herpes simplex virus DNA sequences in cerebrospinal fluid, p. 332-336. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
13. Gopal, R., T. Gibbs, M. J. Slomka, J. Whitworth, L. M. Carpenter, A. Vyse, and D. W. Brown. 2000. A monoclonal blocking EIA for herpes simplex virus type 2 (HSV-2) antibody: validation for seroepidemiological studies in Africa. J. Virol. Methods 87:71-80.
14. Gronroos, M., and E. Honkonen. 1983. Cervical and serum IgA and serum IgG antibodies to Chlamydia trachomatis and herpes simplex virus in threatened abortion: a prospective study. Br. J. Obstet. Gynecol. 90:167-170.
15. Hocini, H., A. Barra, L. Belec, S. Iscaki, J. L. Preud'homme, J. Pillot, and J. P. Bouvet. 1995. Systemic and secretory humoral immunity in the normal human vaginal tract. Scand. J. Immunol. 42:269-274.
16. Koelle, D. M., M. Schomogyi, and L. Corey. 2000. Antigen-specific T cells localize to the uterine cervix in women with genital herpes simplex virus type 2 infection. J. Infect. Dis. 182:662-670.
17. Koelle, D. M., H. B. Chen, M. A. Gavin, A. Wald, W. W. Kwok, and L. Corey. 2001. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells. J. Immunol. 166:4049-4058.
18. Mantero, G., A. Zonaro, A. Albertini, P. Bertolo, and D. Primi. 1991. DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction. Clin. Chem. 37:422-429.
19. Mbopi-Keou, F. X., G. Gresenguet, P. Mayaud, H. A. Weiss, R. Gopal, M. Matta, J. L. Paul, D. W. Brown, R. J. Hayes, D. C. Mabey, and L. Belec. 2000. Interactions between herpes simplex virus type 2 and HIV infection in African women: opportunities for intervention. J. Infect. Dis. 182:1090-1096.
20. McDermott, M. R., L. J. Brais, and M. J. Evelegh. 1990. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J. Gen. Virol. 71:1497-1504.
21. Merriman, H., S. Woods, C. Winter, A. Fahnlander, and L. Corey. 1984. Secretory IgA antibodies in CVS secretions from women with genital infection due to herpes simplex virus. J. Infect. Dis. 149:505-510.
22. Mostad, S. B., J. K. Kreiss, A. J. Ryncarz, K. Mandaliya, B. Chohan, J. Ndinya-Achola, J. J. Bwayo, and L. Corey. 2000. Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency. J. Infect. Dis. 181:58-63.
23. Murphy, J. F., D. F. Murphy, S. Barker, M. L. Mylotte, B. M. Coughlan, and G. R. B. Skinner. 1985. Neutralizing antibody against type 1 and 2 herpes simplex virus in cervical mucus of women suffering with intra-epithelial neoplasia. Med. Microbiol. Immunol. 174:73-80.
24. Parr, E. L., and M. B. Parr. 1997. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2. J. Virol. 71:8109-8115.
25. Persson, E., P. Eneroth, and S. Jeansson. 1988. Secretory IgA against herpes simplex virus in cervical secretions. Genitourin. Med. 64:373-377.
26. Posavad, C. M., D. M. Koelle, and L. Corey. 1998. Tipping the scales of herpes simplex virus reactivation: the important responses are local. Nat. Med. 4:381-382.
27. Quesnel, A., S. Cu-Uvin, D. Murphy, R. L. Ashley, T. Flanigan, and M. R. Neutra. 1997. Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women. J. Immunol. Methods 202:153-161.
28. Rouse, B. T., and M. Glerynska. 2001. Immunity to herpes simplex virus: a hypothesis. Herpes 8(Suppl. 1):2A-5A.
29. Si-Mohamed, A., M. D. Kazatchkine, I. Heard, C. Goujon, T. Prazuck, G. Aymard, G. Cessot, Y. H. Kuo, M. C. Bernard, B. Diquet, J. E. Malkin, L. Gutmann, and L. Belec. 2000. Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy. J. Infect. Dis. 18:112-122.
30. Stabell, E. C., and P. D. Olivo. 1992. Isolation of a cell line for rapid and sensitive histochemical assay for the detection of herpes simplex virus. J. Virol. Methods 38:195-202.
31. Vogel, J. U., B. Weber, and H. W. Doerr. 1994. Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerase chain reaction and subsequent fragment length polymorphism analysis. Zentbl. Bakteriol. 281:502-512.
32. Wald, A., J. Zeh, S. Selke, R. L. Ashley, and L. Corey. 1995. Virological characteristics of subclinical and symptomatic genital herpes infections. N. Engl. J. Med. 333:770-775.
33. Wald, A., J. Zeh, S. Selke, T. Warren, R. Ashley, and L. Corey. 2002. Genital shedding of herpes simplex virus among men. J. Infect. Dis 186(Suppl. 1):S34-S39.